These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35436772)

  • 1. In brief: Expanded heart failure indication for empagliflozin (Jardiance).
    Med Lett Drugs Ther; 2022 Apr; 64(1648):57. PubMed ID: 35436772
    [No Abstract]   [Full Text] [Related]  

  • 2. Empagliflozin (Jardiance) for heart failure.
    Med Lett Drugs Ther; 2020 Nov; 62(1611):177-178. PubMed ID: 33438858
    [No Abstract]   [Full Text] [Related]  

  • 3. Empagliflozin (Jardiance) for heart failure with reduced ejection fraction.
    Med Lett Drugs Ther; 2021 Nov; 63(1636):171-172. PubMed ID: 35085205
    [No Abstract]   [Full Text] [Related]  

  • 4. Ertugliflozin for type 2 diabetes.
    Med Lett Drugs Ther; 2018 Apr; 60(1545):70-72. PubMed ID: 29667948
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison chart: SGLT2 inhibitors.
    Med Lett Drugs Ther; 2020 Nov; 62(1611):e2-e4. PubMed ID: 33429417
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapagliflozin/saxagliptin (Qtern) for type 2 diabetes.
    Med Lett Drugs Ther; 2018 Mar; 60(1543):55-56. PubMed ID: 29635266
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for type 2 diabetes.
    Med Lett Drugs Ther; 2022 Nov; 64(1663):177-184. PubMed ID: 36384763
    [No Abstract]   [Full Text] [Related]  

  • 8. Canagliflozin (Invokana). A "me-too" of the dangerous dapagliflozin.
    Prescrire Int; 2015 Feb; 24(157):33-5. PubMed ID: 25802910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapagliflozin (Farxiga) - a new indication for heart failure.
    Med Lett Drugs Ther; 2020 Jun; 62(1601):102-103. PubMed ID: 32724023
    [No Abstract]   [Full Text] [Related]  

  • 10. Empagliflozin (Jardiance). Type 2 diabetes: no rush to use this drug.
    Prescrire Int; 2016 Jun; 25(172):145-8. PubMed ID: 27486640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In brief: Canagliflozin and lower limb amputations.
    Med Lett Drugs Ther; 2020 Sep; 62(1607):152. PubMed ID: 32960870
    [No Abstract]   [Full Text] [Related]  

  • 12. Dapagliflozin for heart failure: is it a class effect?
    Raj GM; Wyawahare M
    Future Cardiol; 2021 Mar; 17(2):355-361. PubMed ID: 32755319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ▼ Empagliflozin, diabetes and outcomes.
    Drug Ther Bull; 2016 Jul; 54(7):78-81. PubMed ID: 27417322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliflozins: ketoacidosis.
    Prescrire Int; 2016 Mar; 25(169):68. PubMed ID: 27152399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes.
    Med Lett Drugs Ther; 2019 Feb; 61(1566):26-28. PubMed ID: 30845101
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease.
    Reifsnider OS; Kansal AR; Gandhi PK; Cragin L; Brand SB; Pfarr E; Fahrbach K; Ustyugova A
    BMJ Open Diabetes Res Care; 2021 May; 9(1):. PubMed ID: 33941549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stronger Warning for Two Diabetes Drugs.
    Aschenbrenner DS
    Am J Nurs; 2016 Oct; 116(10):26. PubMed ID: 27684766
    [No Abstract]   [Full Text] [Related]  

  • 18. Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer.
    Sezer H; Yazıcı D; Deyneli O; Meriçöz Ç; Esin A; Alper E
    Endokrynol Pol; 2020; 71(3):283-284. PubMed ID: 32154575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review.
    Rao S
    Adv Ther; 2022 Feb; 39(2):845-861. PubMed ID: 34881413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for type 2 diabetes.
    Med Lett Drugs Ther; 2019 Nov; 61(1584):169-178. PubMed ID: 31770362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.